Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03897374 · ClinicalTrials.gov registry record

Strategic Targeting for Optimal Prevention of Cancer

A clinical trial of Early Detection of Cancer, sponsored by ClinLogic.

Recruiting
Registry status
120,000
Enrollment target
1
Study location

NCT03897374 is a study of Early Detection of Cancer that is actively recruiting participants, run by ClinLogic. The registered enrollment target is 120,000 participants, above the 22,765-participant average among 8 other Early Detection of Cancer trials with a reported enrollment target (427% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03897374, a study of Early Detection of Cancer, is actively recruiting participants, sponsored by ClinLogic.

RECRUITING
Registry status
120,000 participants
Enrollment target
1
Study location

Study Summary

The primary goal of the study is to record data over the observation period to evaluate the clinical benefit of using hereditary cancer genomic diagnostics to assess overall hereditary genetic cancer risk profile and to help guide physicians to pursue preventative measures, which may lead to early detection and treatment of the condition.

Conditions Studied

Early Detection of Cancer

Interventions

  • DIAGNOSTIC_TEST Genetic Testing

Study Locations (1)

Texas

  • Sunbeam Clinical - Prosper

Trial Details

FieldValue
Enrollment Target 120,000 participants
Start Date 2025-03-26
Est. Completion 2028-12-31

Sponsor

ClinLogic

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03897374

The ClinicalTrials.gov registry entry for NCT03897374 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 120,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 22,765-participant average among 8 other Early Detection of Cancer trials with a reported enrollment target (427% higher). The listed sponsor is ClinLogic, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Early Detection of Cancer appearing as the primary indexed condition, and to 1 intervention - of which Genetic Testing is the first listed.

NCT03897374 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03897374 about?

NCT03897374 is a clinical study titled "Strategic Targeting for Optimal Prevention of Cancer". The primary goal of the study is to record data over the observation period to evaluate the clinical benefit of using hereditary cancer genomic diagnostics to assess overall hereditary genetic cancer risk profile and to help guide physicians to pursue preventative measures, which may lead to early d...

What is the current status of trial NCT03897374?

This trial is currently recruiting. The enrollment target is 120,000 participants. The study started on 2025-03-26. Estimated completion is 2028-12-31.

What conditions does trial NCT03897374 study?

This clinical trial studies the following conditions: Early Detection of Cancer.

What interventions are being tested in trial NCT03897374?

The interventions under investigation include: Genetic Testing (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03897374?

This trial is sponsored by ClinLogic, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03897374 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Early Detection of Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Early Detection of Cancer

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.